Pax Financial Group, LLC Incyte Corp Transaction History

Pax Financial Group, LLC

$488 Million
Q2 2024

A detailed history of Pax Financial Group, LLC transactions in Incyte Corp stock. As of the latest transaction made, Pax Financial Group, LLC holds 13,807 shares of INCY stock, worth $912,642. This represents 0.17% of its overall portfolio holdings.

Number of Shares

13,807

Previous 14,388 4.04%

Holding current value

$912,642

Previous $819,000 2.08%

% of portfolio

0.17%

Previous 0.17%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $29,735 - $37,038	-581 Reduced 4.04%	13,807 $836,000
Q1 2024 May 13, 2024	SELL	$56.55 - $66.59 $20,018 - $23,572	-354 Reduced 2.4%	14,388 $819,000
Q4 2023 Feb 12, 2024	SELL	$52.16 - $64.19 $16,221 - $19,963	-311 Reduced 2.07%	14,742 $925,000
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $26,458 - $30,195	458 Added 3.14%	15,053 $869,000
Q2 2023 Jul 18, 2023	BUY	$60.95 - $75.51 $30,048 - $37,226	493 Added 3.5%	14,595 $908,000
Q1 2023 May 11, 2023	BUY	$70.23 - $86.01 $25,212 - $30,877	359 Added 2.61%	14,102 $1.02 Million
Q4 2022 Feb 10, 2023	SELL	$67.18 - $84.11 $117,229 - $146,771	-1,745 Reduced 11.27%	13,743 $1.1 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $38,053 - $47,644	575 Added 3.86%	15,488 $1.03 Million
Q2 2022 Aug 09, 2022	SELL	$66.18 - $83.18 $98,674 - $124,021	-1,491 Reduced 9.09%	14,913 $1.13 Million
Q1 2022 May 10, 2022	BUY	$66.02 - $79.71 $111,177 - $134,231	1,684 Added 11.44%	16,404 $1.3 Million
Q4 2021 Feb 07, 2022	BUY	$63.34 - $74.11 $283,573 - $331,790	4,477 Added 43.71%	14,720 $1.08 Million
Q3 2021 Oct 29, 2021	BUY	$68.67 - $84.02 $202,782 - $248,111	2,953 Added 40.51%	10,243 $705,000
Q2 2021 Aug 13, 2021	BUY	$79.87 - $87.53 $203,349 - $222,851	2,546 Added 53.67%	7,290 $613,000
Q1 2021 May 10, 2021	BUY	$76.02 - $100.5 $360,638 - $476,772	4,744 New	4,744 $386,000

Others Institutions Holding INCY

# of Institutions

629

Shares Held

198M

Call Options Held

766K

Put Options Held

476K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $14.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pax Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pax Financial Group, LLC with notifications on news.

Account

Pax Financial Group, LLC Incyte Corp Transaction History